A Bayesian reanalysis of the CULPRIT-SHOCK trial

Our Bayesian reanalysis provides intuitive insights by quantifying probabilities of treatment effect sizes, offering further evidence favouring the culprit lesion-only PCI strategy in AMI patients with CS and multivessel disease. The analysis demonstrates a high probability of overall benefit, with a notable chance of achieving a minimally clinically important difference, particularly in specific subgroups. These findings not only support the consideration of culprit lesion-only PCI in certain patient populations but also underscore the need for careful risk-benefit assessment. Furthermore, our hypothesis-generating subgroup analyses, which show varying probabilities of achieving MCID, illuminate promising avenues for future targeted investigations in this critical patient population.

Authors

Institutions

Publication Details

Journal
European Heart Journal Acute Cardiovascular Care
Published
2024-09-12
DOI
https://doi.org/10.1093/ehjacc/zuae104
Citations
4
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
4.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Bayesian reanalysis of the CULPRIT-SHOCK trial

Malte Kelm, Christian Jung, Anne Freund, Bernhard Wernly et al.
4 citations
European Heart Journal Acute Cardiovascular Care
Health Systems, Economic Evaluations, Quality of Life
4.52
article

A Bayesian reanalysis of the CULPRIT-SHOCK trial

Malte Kelm, Christian Jung, Anne Freund, Bernhard Wernly, Maryna Masyuk, Hölger Thiele, Benedikt Schrage, İbrahim Akın, Steffen Schneider, Sabrina Schlesinger, Uwe Zeymer, Steffen Desch, Janine Pöss
article en
4 citations

Abstract

Our Bayesian reanalysis provides intuitive insights by quantifying probabilities of treatment effect sizes, offering further evidence favouring the culprit lesion-only PCI strategy in AMI patients with CS and multivessel disease. The analysis demonstrates a high probability of overall benefit, with a notable chance of achieving a minimally clinically important difference, particularly in specific subgroups. These findings not only support the consideration of culprit lesion-only PCI in certain patient populations but also underscore the need for careful risk-benefit assessment. Furthermore, our hypothesis-generating subgroup analyses, which show varying probabilities of achieving MCID, illuminate promising avenues for future targeted investigations in this critical patient population.

European Heart Journal Acute Cardiovascular CareVol. 13(10)
University of Mannheim (DE), Heidelberg University (DE), Paracelsus Medical University (AT), University Hospital Heidelberg (DE), Düsseldorf University Hospital (DE), Stiftung Institut für Herzinfarktforschung (DE), Leipzig Heart Institute (DE), Krankenhaus Oberndorf (AT), German Centre for Cardiovascular Research (DE), Klinikum Ludwigshafen (DE), Deutsches Diabetes-Zentrum e.V. (DE), German Center for Diabetes Research (DE), Saint John of God Hospital, Heinrich Heine University Düsseldorf (DE)
Good health and well-being
Openalex Percentile: Top 5%
Health Systems, Economic Evaluations, Quality of Life
4.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.